Molecular Mimicry between SARS-CoV-2 Proteins and Human Self-Antigens
  • View Times: 30
  • |
  • Release Date: 2024-02-12
  • COVID-19
  • SARS-CoV-2
  • molecular mimicry
  • immune tolerance
  • autoimmune disorders
  • central nervous system
Video Introduction

This video is adapted from 10.3390/microorganisms11122902

SARS-CoV-2 can trigger autoimmune central nervous system (CNS) diseases in genetically susceptible individuals, a mechanism poorly understood. Molecular mimicry (MM) has been identified in other viral diseases as potential triggers of autoimmune CNS events.

Full Transcript
Video Production Service